图:用于恢复生物网络的新贝叶斯方法
Aapo E Korhonen1, Olli Sarala1, Tuomas Hautamäki1
1Research Unit of Mathematical Sciences, University of Oulu, Oulu, Finland.
PLoS computational biology
|October 30, 2025
概括
这项研究介绍了一种新的贝叶斯高斯图形模型 (GGM),具有快速的,分层的矩阵-F前. 该方法提供了具有竞争力的网络恢复,并优于现有的欧米克数据分析方法.
科学领域:
- 计算生物学 计算生物学
- 统计遗传学 统计遗传学
- 生物信息学是一种生物信息学.
背景情况:
- 高斯图形模型 (GGM) 对于分析高维欧米数据中的部分相关结构至关重要.
- 对GGM的贝叶斯实现正在获得引力,但在超参数调整,边缘选择,可扩展性和先前选择方面面临挑战.
研究的目的:
- 引入一个新的贝叶斯基数GGM,具有层次矩阵-F先验和快速实现.
- 解决现有的贝叶斯GGM方法的局限性,包括计算效率和网络恢复.
主要方法:
- 开发了一种新的贝叶斯式GGM,利用一个等级矩阵-F之前.
- 实施了快速计算方法,使用了通用期望最大化算法.
- 通过精密矩阵条件数约束和使用假发现率控制可靠间隔的边缘选择引入了一种新的收缩超参数调整方法.
主要成果:
- 与最先进的方法相比,拟议的先进方法证明了具有竞争力的网络恢复能力.
- 该方法显示了在恢复生物学上有意义的网络方面具有良好的特性.
- 一般化期望最大化算法在马尔科夫链蒙特卡洛方法上提供了显著的计算优势.
结论:
- 小说贝叶斯式GGM与等级矩阵-F前期提供一个高效和有效的工具,用于奥米克数据分析.
- 该方法增强了网络恢复,提供了更好的计算性能,并促进了社区检测.
- R包HMFGraph可用于实际应用.
相关概念视频
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
231
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
231
Protein Networks
2.8K
2.8K
Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Model Approaches for Pharmacokinetic Data: Physiological Models
244
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
244
Biostatistics: Overview
718
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
718
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
477
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
477


